Cargando…
Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
B-lineage acute lymphoblastic leukemia (B-ALL) is the most common type of cancer seen in children and is characterized by a variable clinical course. Although there have been remarkable improvements in the therapy outcomes of pediatric B-ALL, treatment failure remains the leading-cause of death in 1...
Autor principal: | Alsagaby, Suliman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747058/ https://www.ncbi.nlm.nih.gov/pubmed/31565196 http://dx.doi.org/10.4081/oncol.2019.435 |
Ejemplares similares
-
Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemia
por: Masic, Dino, et al.
Publicado: (2022) -
Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
por: Wang, Han, et al.
Publicado: (2023) -
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2019) -
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
por: Wei, Guoqing, et al.
Publicado: (2017) -
Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia
por: Bartholomew, Joy L., et al.
Publicado: (2018)